Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Lasmiditan","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=lasmiditan","facts":[{"label":"Active ingredient \/ generic name","value":"lasmiditan"}]},{"title":"Lyrica 150 mg (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=lyrica-150-mg","facts":[{"label":"Active ingredient \/ generic name","value":"Pregabalin"},{"label":"ATC code","value":"N03AX16"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed SPL version 16; effective 2026-01-08; retrieved 2026-11-04"}],"sources":[{"label":"REYVOW (lasmiditan) \u2014 US prescribing information, DailyMed","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=aea3358c-ff41-4490-9e6d-c7bf7b3de13f"},{"label":"Supporting reference identified in reviewed research","url":"https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35883","available":true}}